Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Robotic Assisted Endovascular Systems Market Size Forecast: How Big Could The Market Get By 2030?
The robotic assisted endovascular systems market size has shown strong growth recently. It is projected to increase from $32.01 billion in 2025 to $34.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. This past growth can be attributed to factors such as an increase in cardiovascular disease cases, growth in catheter based interventions, the expansion of interventional radiology units, a rising preference for minimally invasive surgery, and improvements in vascular imaging.
The robotic assisted endovascular systems market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $48.94 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.9%. This projected increase over the forecast period can be linked to several factors, including the proliferation of robotic vascular labs, a heightened need for precision-guided medical interventions, the broadening scope of neurovascular robotic procedures, advancements in remote surgery functionalities, and increased capital expenditure by hospitals on robotic operating facilities. Key developments expected during this timeframe encompass the advancement of robotic catheter navigation, a growing embrace of these systems in minimally invasive vascular operations, the evolution of imaging-guided robotic platforms, a surge in the application of remote robotic interventions, and the incorporation of sophisticated precision vascular control mechanisms.
Get A Free Sample Report With In-Depth Market Insights:
Robotic Assisted Endovascular Systems Market Growth Backed By Core Demand Fundamentals
The increasing occurrence of cardiovascular and neurovascular conditions is anticipated to drive expansion in the robotic-assisted endovascular systems market. These conditions impact the heart, blood vessels, and brain’s circulatory system, encompassing issues like coronary artery disease, stroke, and cerebral aneurysms, and are a primary global contributor to fatalities and enduring disabilities. The rise in cardiovascular and neurovascular diseases stems from an aging global demographic coupled with a greater incidence of lifestyle-associated risk factors such as obesity, high blood pressure, and a lack of physical activity. Robotic-assisted endovascular systems aid in addressing these diseases by facilitating extremely precise, minimally intrusive navigation within blood vessels, thereby enhancing the accuracy, safety, and overall clinical results for intricate vascular procedures. For example, in January 2024, the American Heart Association, a US-based non-profit, reported that the age-adjusted mortality rate for cardiovascular disease climbed to 233.3 per 100,000 in 2024, marking a 4.0% increase from 224.4 per 100,000 in 2023. Consequently, the growing occurrence of cardiovascular and neurovascular diseases is fueling the expansion of the robotic-assisted endovascular systems market.
Robotic Assisted Endovascular Systems Market Segment Breakdown: Which Categories Lead On Revenue?
The robotic assisted endovascular systems market covered in this report is segmented –
1) By Component: Hardware; Software; Services
2) By Product: Robotic Catheter Systems; Robotic Guidewire Systems; Robotic Angioplasty Systems; Other Products
3) By Technology: Robotic Catheter Systems; AI-Assisted Navigation Systems; Imaging-Guided Robotic Platforms; Haptic Feedback Systems; Autonomous Robotic Systems
4) By Application: Coronary Interventions; Peripheral Vascular Interventions; Neurovascular Interventions; Other Applications
5) By End-User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Research And Academic Institutes; Other End-Users
Subsegments:
1) By Hardware: Robotic Control Units; Robotic Catheter Systems; Navigation Consoles; Imaging Integration Modules; Surgical Instrument Arms
2) By Software: Navigation Software Platforms; Imaging Processing Software; Procedure Planning Software; Data Management Software; Clinical Decision Support Software
3) By Services: Installation Services; Maintenance And Repair Services; Training And Education Services; System Upgradation Services
Robotic Assisted Endovascular Systems Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the robotic assisted endovascular systems market are prioritizing the integration of robotics with advanced imaging and navigation systems, such as fully remote endovascular robotic platforms. This effort aims to enhance procedural precision, facilitate complex vascular navigation, and broaden access to specialized medical care. Fully remote endovascular robotic platforms are defined as robotic systems that combine real-time fluoroscopic imaging with preoperative CT and MRI data to guide the robotic manipulation of catheters and guidewires during endovascular procedures, while also allowing clinicians to operate from a distant console. An illustrative example of this trend is the introduction, in October 2025, by Remedy Robotics, a US-based medical technology company, of the Remedy N1 System. This endovascular surgical robotic platform is specifically designed to support fully remote neurointerventional procedures. Engineered to boost accuracy and clinical workflow, the system integrates automated CT and MRI image preprocessing with live fluoroscopic imaging for real-time navigation, permits simultaneous robotic control of up to four endovascular devices, and features a portable operator console with secure audiovisual connectivity to facilitate remote procedural execution.
Robotic Assisted Endovascular Systems Market Key Participants And Competitive Landscape
Major companies operating in the robotic assisted endovascular systems market are Johnson & Johnson, Siemens Healthineers AG, Corindus Vascular Robotics Inc., Cordis Corporation, MicroPort Scientific Corporation, Hansen Medical Inc., Robocath S.A.S., Magnetecs Corporation, Cathbot Robot Co. Ltd., EKOS Corporation, Stereotaxis Inc., Imperative Care Inc., WeMed Medical Technology Co. Ltd., Lombard Medical Limited, Endovascular Robotics Inc., SS Innovations International Inc., Visionary Medicare Co. Ltd., Vantis Vascular Inc., Microbot Medical Inc., Sentante Ltd.
View The Full Robotic Assisted Endovascular Systems Market Report:
Robotic Assisted Endovascular Systems Market Geographic Analysis: Where Is Demand Accelerating Fastest?
Europe was the largest region in the robotic assisted endovascular systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic assisted endovascular systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model